“…4 The proportion of squamous cell differentiation, either <30% or ≥30%, does not appear to predict overall survival. 5 The relative rarity of ASCP has limited the characterization of clinicopathological variables associated with outcome to case studies, [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23] single institution studies with a paucity of patients 3,5,[24][25][26][27][28][29] or examination of administrative datasets with limited co-variate availability. 30,31 Most series report a poor prognosis for patients with ASCP with median overall survival ranging from 4 to 19 months depending on surgical resection and/or the receipt of adjuvant chemotherapy.…”